Favipiravir as a potential countermeasure against neglected and emerging RNA viruses - ScienceDirect
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Publications | IAME
Ebola virus disease: An emerging and re-emerging viral threat - ScienceDirect
From Ancient to Emerging Infections: The Odyssey of Viruses in the Male Genital Tract | Physiological Reviews
Potential drug development and therapeutic approaches for clinical intervention in COVID-19 - ScienceDirect
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses - ScienceDirect
Potential drug development and therapeutic approaches for clinical intervention in COVID-19 - ScienceDirect
CBRNE - Viral Hemorrhagic Fevers: Practice Essentials, Pathophysiology, Etiology
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19 - ScienceDirect
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules - ScienceDirect
Favipiravir and severe acute respiratory syndrome coronavirus 2 in hamster model | bioRxiv
From Ancient to Emerging Infections: The Odyssey of Viruses in the Male Genital Tract | Physiological Reviews
Potential drug development and therapeutic approaches for clinical intervention in COVID-19 - ScienceDirect
Favipiravir (6‐Fluoro‐3‐hydroxy‐2‐pyrazinecarboxamide) a Broad Spectrum Inhibitor of Viral RNA Polymerase in COVID‐19 Treatment - Gaonkar - 2021 - ChemistrySelect - Wiley Online Library
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules - ScienceDirect
CBRNE - Viral Hemorrhagic Fevers: Practice Essentials, Pathophysiology, Etiology
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
Potential drug development and therapeutic approaches for clinical intervention in COVID-19 - ScienceDirect
Favipiravir (6‐Fluoro‐3‐hydroxy‐2‐pyrazinecarboxamide) a Broad Spectrum Inhibitor of Viral RNA Polymerase in COVID‐19 Treatment - Gaonkar - 2021 - ChemistrySelect - Wiley Online Library
Η Κάνναβη και το Σύνδρομο Down | Το Βοτάνι
Potential drug development and therapeutic approaches for clinical intervention in COVID-19 - ScienceDirect
New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections - De Clercq - 2019 - Chemistry – An Asian Journal - Wiley Online Library
Potential drug development and therapeutic approaches for clinical intervention in COVID-19 - ScienceDirect
Ebola virus disease: An emerging and re-emerging viral threat - ScienceDirect